DDrare: Database of Drug Development for Rare Diseases

Target Gene/Pathway（薬物標的遺伝子／パスウェイリスト）💬 Info on mouse-over

A B C D E F G H I J K L M N O PQR S T U V WXYZother

107 / 286 pathways

No.	KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related	KEGG GENES	KEGG DRUG	DrugBank	指定難病告示番号
1	Acute myeloid leukemia 💬	1件: RARA 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
2	Adrenergic signaling in cardiomyocytes 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
3	AGE-RAGE signaling pathway in diabetic complications 💬	2件: VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
4	Alanine, aspartate and glutamate metabolism 💬	4件: ABAT, ALDH5A1, GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
5	Alcoholism 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
6	Alcoholism 💬	2件: DRD1, DRD2 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
7	Aldosterone synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
8	Aldosterone synthesis and secretion 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
9	Alzheimer disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
10	Alzheimer disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
11	Amphetamine addiction 💬	2件: CACNA1C, CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
12	Amphetamine addiction 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
13	Amphetamine addiction 💬	1件: DRD1 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
14	Amphetamine addiction 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
15	Amyotrophic lateral sclerosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
16	Apoptosis - multiple species 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
17	Arrhythmogenic right ventricular cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
18	Axon guidance 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
19	B cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
20	beta-Alanine metabolism 💬	3件: ABAT, GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
21	Bile secretion 💬	1件: CA2 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
22	Bile secretion 💬	1件: CA2 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
23	Bile secretion 💬	1件: CA2 💬	D00653 💬	Dorzolamide	1件: 90 💬
24	Bile secretion 💬	1件: CA2 💬	D07871 💬	Dorzolamide	1件: 90 💬
25	Bladder cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
26	Butanoate metabolism 💬	4件: ABAT, ALDH5A1, GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
27	C-type lectin receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
28	Calcium signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
29	Calcium signaling pathway 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
30	Calcium signaling pathway 💬	2件: DRD1, DRD5 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
31	Calcium signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
32	Calcium signaling pathway 💬	1件: PTGFR 💬	D08661 💬	Unoprostone	1件: 90 💬
33	Calcium signaling pathway 💬	2件: VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
34	cAMP signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
35	cAMP signaling pathway 💬	3件: DRD1, DRD2, DRD5 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
36	Carbohydrate digestion and absorption 💬	1件: CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
37	Cardiac muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
38	Cellular senescence 💬	1件: CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
39	Cellular senescence 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
40	cGMP-PKG signaling pathway 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	D02076 💬	Brimonidine	2件: 13, 90 💬
41	cGMP-PKG signaling pathway 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	D07540 💬	Brimonidine	2件: 13, 90 💬
42	cGMP-PKG signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
43	cGMP-PKG signaling pathway 💬	1件: PDE5A 💬	D02229 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
44	cGMP-PKG signaling pathway 💬	1件: PDE5A 💬	D08514 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
45	cGMP-PKG signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
46	Cholinergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
47	Circadian entrainment 💬	2件: CACNA1C, CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
48	Circadian entrainment 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
49	Circadian entrainment 💬	2件: MTNR1A, MTNR1B 💬	D08170 💬	Melatonin	11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
50	Cocaine addiction 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
51	Cocaine addiction 💬	2件: DRD1, DRD2 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
52	Collecting duct acid secretion 💬	1件: CA2 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
53	Collecting duct acid secretion 💬	1件: CA2 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
54	Collecting duct acid secretion 💬	1件: CA2 💬	D00653 💬	Dorzolamide	1件: 90 💬
55	Collecting duct acid secretion 💬	1件: CA2 💬	D07871 💬	Dorzolamide	1件: 90 💬
56	Cortisol synthesis and secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
57	Cortisol synthesis and secretion 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
58	Cushing syndrome 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
59	Cushing syndrome 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
60	Cysteine and methionine metabolism 💬	3件: DNMT1, DNMT3A, DNMT3B 💬	D03665 💬	Decitabine	4件: 13, 63, 90, 301 💬
61	Cytokine-cytokine receptor interaction 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
62	Dilated cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
63	Dopaminergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
64	Dopaminergic synapse 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
65	Dopaminergic synapse 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
66	Dopaminergic synapse 💬	3件: PPP3CA, PPP3CB, PPP3CC 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
67	EGFR tyrosine kinase inhibitor resistance 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
68	Estrogen signaling pathway 💬	1件: RARA 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
69	Fluid shear stress and atherosclerosis 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
70	Focal adhesion 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
71	GABAergic synapse 💬	3件: ABAT, GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
72	GABAergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
73	Gap junction 💬	2件: DRD1, DRD2 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
74	Gastric acid secretion 💬	1件: CA2 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
75	Gastric acid secretion 💬	1件: CA2 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
76	Gastric acid secretion 💬	1件: CA2 💬	D00653 💬	Dorzolamide	1件: 90 💬
77	Gastric acid secretion 💬	1件: CA2 💬	D07871 💬	Dorzolamide	1件: 90 💬
78	Gastric cancer 💬	1件: RARB 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
79	Glucagon signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
80	Glutamatergic synapse 💬	2件: CACNA1C, CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
81	Glutamatergic synapse 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
82	GnRH secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
83	GnRH secretion 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
84	GnRH signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
85	Growth hormone synthesis, secretion and action 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
86	HIF-1 signaling pathway 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
87	Human cytomegalovirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
88	Human cytomegalovirus infection 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
89	Human immunodeficiency virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
90	Human papillomavirus infection 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
91	Human T-cell leukemia virus 1 infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
92	Hypertrophic cardiomyopathy 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
93	Insulin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
94	Kaposi sarcoma-associated herpesvirus infection 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
95	Kaposi sarcoma-associated herpesvirus infection 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
96	Long-term potentiation 💬	1件: CACNA1C 💬	D01908 💬	Nilvadipine	1件: 90 💬
97	Long-term potentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
98	MAPK signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
99	MAPK signaling pathway 💬	3件: CACNA1G, CACNA1H, CACNA1I 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
100	MAPK signaling pathway 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
101	MAPK signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
102	MAPK signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
103	Metabolic pathways 💬	4件: ABAT, ALDH5A1, GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
104	Metabolic pathways 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
105	Metabolic pathways 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
106	Metabolic pathways 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D00653 💬	Dorzolamide	1件: 90 💬
107	Metabolic pathways 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D07871 💬	Dorzolamide	1件: 90 💬
108	Metabolic pathways 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
109	Metabolic pathways 💬	3件: DNMT1, DNMT3A, DNMT3B 💬	D03665 💬	Decitabine	4件: 13, 63, 90, 301 💬
110	Metabolic pathways 💬	1件: PDE5A 💬	D02229 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
111	Metabolic pathways 💬	1件: PDE5A 💬	D08514 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
112	MicroRNAs in cancer 💬	3件: DNMT1, DNMT3A, DNMT3B 💬	D03665 💬	Decitabine	4件: 13, 63, 90, 301 💬
113	MicroRNAs in cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
114	Morphine addiction 💬	1件: DRD1 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
115	Natural killer cell mediated cytotoxicity 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
116	Neuroactive ligand-receptor interaction 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	D02076 💬	Brimonidine	2件: 13, 90 💬
117	Neuroactive ligand-receptor interaction 💬	3件: ADRA2A, ADRA2B, ADRA2C 💬	D07540 💬	Brimonidine	2件: 13, 90 💬
118	Neuroactive ligand-receptor interaction 💬	5件: DRD1, DRD2, DRD3, DRD4, DRD5 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
119	Neuroactive ligand-receptor interaction 💬	2件: MTNR1A, MTNR1B 💬	D08170 💬	Melatonin	11件: 6 , 8 , 13, 46, 49, 90, 97, 144, 145, 149, 202 💬
120	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00244 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
121	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00972 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
122	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01357 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
123	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01402 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
124	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01637 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
125	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D02032 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
126	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D02286 💬	Betamethasone	6件: 2 , 28, 46, 90, 96, 235 💬
127	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00292 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
128	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00975 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
129	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01510 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
130	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01615 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
131	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01632 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
132	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01948 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
133	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D02174 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
134	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D02591 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
135	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D02592 💬	Dexamethasone	25件: 13, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 74, 75, 81, 83, 84, 90, 96, 97, 162, 222, 235, 283, 296, 299 💬
136	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D01825 💬	Fluocinolone acetonide	1件: 90 💬
137	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00385 💬	Triamcinolone	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
138	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00983 💬	Triamcinolone	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
139	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00984 💬	Triamcinolone	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
140	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D00985 💬	Triamcinolone	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
141	Neuroactive ligand-receptor interaction 💬	1件: NR3C1 💬	D06216 💬	Triamcinolone	8件: 35, 46, 56, 70, 90, 96, 226, 298 💬
142	Neuroactive ligand-receptor interaction 💬	1件: PTGFR 💬	D08661 💬	Unoprostone	1件: 90 💬
143	Neurotrophin signaling pathway 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
144	Nitrogen metabolism 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
145	Nitrogen metabolism 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
146	Nitrogen metabolism 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D00653 💬	Dorzolamide	1件: 90 💬
147	Nitrogen metabolism 💬	13件: CA1, CA12, CA13, CA14, CA2, CA3, CA4, CA5A, CA5B, CA6, CA7, CA8, CA9 💬	D07871 💬	Dorzolamide	1件: 90 💬
148	Non-small cell lung cancer 💬	1件: RARB 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
149	Oocyte meiosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
150	Osteoclast differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
151	Oxytocin signaling pathway 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
152	Oxytocin signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
153	Pancreatic cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
154	Pancreatic secretion 💬	1件: CA2 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
155	Pancreatic secretion 💬	1件: CA2 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
156	Pancreatic secretion 💬	1件: CA2 💬	D00653 💬	Dorzolamide	1件: 90 💬
157	Pancreatic secretion 💬	1件: CA2 💬	D07871 💬	Dorzolamide	1件: 90 💬
158	Parkinson disease 💬	2件: DRD1, DRD2 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
159	Pathways in cancer 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
160	Pathways in cancer 💬	2件: RARA, RARB 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
161	Pathways of neurodegeneration - multiple diseases 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
162	Pathways of neurodegeneration - multiple diseases 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
163	PD-L1 expression and PD-1 checkpoint pathway in cancer 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
164	Phenylalanine metabolism 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
165	Phospholipase D signaling pathway 💬	1件: PTGFR 💬	D08661 💬	Unoprostone	1件: 90 💬
166	PI3K-Akt signaling pathway 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
167	PI3K-Akt signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
168	Prion disease 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
169	Prion disease 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
170	Propanoate metabolism 💬	1件: ABAT 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
171	Proteoglycans in cancer 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
172	Proximal tubule bicarbonate reclamation 💬	2件: CA2, CA4 💬	D00218 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
173	Proximal tubule bicarbonate reclamation 💬	2件: CA2, CA4 💬	D01196 💬	Acetazolamide	7件: 13, 86, 90, 115, 155, 225, 230 💬
174	Proximal tubule bicarbonate reclamation 💬	2件: CA2, CA4 💬	D00653 💬	Dorzolamide	1件: 90 💬
175	Proximal tubule bicarbonate reclamation 💬	2件: CA2, CA4 💬	D07871 💬	Dorzolamide	1件: 90 💬
176	Purine metabolism 💬	1件: PDE5A 💬	D02229 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
177	Purine metabolism 💬	1件: PDE5A 💬	D08514 💬	Sildenafil	17件: 6 , 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301 💬
178	Rap1 signaling pathway 💬	1件: DRD2 💬	D00059 💬	Levodopa	8件: 2 , 4 , 6 , 17, 90, 140, 164, 201 💬
179	Rap1 signaling pathway 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
180	Rap1 signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
181	Ras signaling pathway 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
182	Ras signaling pathway 💬	3件: PGF, VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
183	Relaxin signaling pathway 💬	2件: VEGFA, VEGFB 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
184	Renal cell carcinoma 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
185	Renin secretion 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
186	Renin secretion 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
187	Retrograde endocannabinoid signaling 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
188	Rheumatoid arthritis 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
189	Serotonergic synapse 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
190	Serotonergic synapse 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
191	Small cell lung cancer 💬	1件: RARB 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
192	T cell receptor signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
193	Taste transduction 💬	1件: CACNA1C 💬	D01908 💬	Nilvadipine	1件: 90 💬
194	Taurine and hypotaurine metabolism 💬	2件: GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
195	Th1 and Th2 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
196	Th17 cell differentiation 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
197	Th17 cell differentiation 💬	1件: RARA 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
198	Tight junction 💬	1件: CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
199	Transcriptional misregulation in cancer 💬	1件: NGFR 💬	D11028 💬	Cenegermin	1件: 90 💬
200	Transcriptional misregulation in cancer 💬	1件: RARA 💬	D06543 💬	Vitamin A	3件: 13, 53, 90 💬
201	Tryptophan metabolism 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
202	Tuberculosis 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
203	Type I diabetes mellitus 💬	2件: GAD1, GAD2 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
204	Type II diabetes mellitus 💬	2件: CACNA1C, CACNA1D 💬	D01908 💬	Nilvadipine	1件: 90 💬
205	Type II diabetes mellitus 💬	1件: CACNA1G 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
206	Tyrosine metabolism 💬	1件: DDC 💬	D00558 💬	Carbidopa	9件: 2 , 4 , 6 , 13, 17, 90, 140, 164, 201 💬
207	Valine, leucine and isoleucine degradation 💬	1件: ABAT 💬	D00399 💬	Valproic acid	16件: 2 , 3 , 5 , 6 , 13, 26, 34, 65, 85, 89, 90, 102, 222, 233, 256, 331 💬
208	Vascular smooth muscle contraction 💬	4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬	D01908 💬	Nilvadipine	1件: 90 💬
209	VEGF signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
210	VEGF signaling pathway 💬	1件: VEGFA 💬	D09574 💬	Aflibercept	2件: 90, 166 💬
211	Wnt signaling pathway 💬	5件: PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬	D00184 💬	Cyclosporine	43件: 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬

先頭へ